We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
(+4.5%)
Cap. Flow
+$96.4M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
993
Closed
158
Avg Time Held Equity + Options
4.4
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
3.6
years
Avg Time Held Equity only
4.4
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$18.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$15.5M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$6.8M |
| 4 |
JPMorgan Active Bond ETF
JBND
|
+$5.14M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$8.95M |
| 2 |
Palantir
PLTR
|
+$7.81M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$5.25M |
| 4 |
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$3.68M |
| 5 |
UnitedHealth
UNH
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 16.97% |
| 3 | Healthcare | 8.95% |
| 4 | Financials | 7.08% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Collegium Pharmaceutical
COLL
$755M
| $287 | ﹤0.01% |
10
-39
| -80% | -$1.29K |
2024 Q2
2 quarters
|
|
3302
Shore Bancshares
SHBI
$749M
| $285 | ﹤0.01% |
+18
| New | +$279 |
2024 Q4
0 quarters
|
|
3303
Organogenesis Holdings
ORGO
$143M
| $282 | ﹤0.01% |
+88
| New | +$295 |
2024 Q4
0 quarters
|
|
3304
DELISTED
Udemy
UDMY
| $280 | ﹤0.01% |
+34
| New | +$274 |
2024 Q4
0 quarters
|
|
3305
Republic Bancorp
RBCAA
$1.8B
| $279 | ﹤0.01% |
+4
| New | +$285 |
2024 Q4
0 quarters
|
|
3306
Entrada Therapeutics
TRDA
$192M
| $277 | ﹤0.01% |
+16
| New | +$290 |
2024 Q4
0 quarters
|
|
3307
DELISTED
Apogee Therapeutics
APGE
| $272 | ﹤0.01% |
6
-5
| -45% | -$255 |
2024 Q3
1 quarter
|
|
3308
Aviat Networks
AVNW
$251M
| $272 | ﹤0.01% |
15
| – | – |
2023 Q4
4 quarters
|
|
3309
Clover Health Investments
CLOV
$2.48B
| $271 | ﹤0.01% |
+85
| New | +$304 |
2024 Q4
0 quarters
|
|
3310
Mineralys Therapeutics
MLYS
$1.89B
| $271 | ﹤0.01% |
22
| – | – |
2023 Q4
4 quarters
|
|
3311
Hovnanian Enterprises
HOV
$610M
| $268 | ﹤0.01% |
2
| – | – |
2023 Q3
5 quarters
|
|
3312
Centerspace
CSR
$943M
| $265 | ﹤0.01% |
4
| – | – |
2023 Q2
6 quarters
|
|
3313
Mama's Creations
MAMA
$623M
| $263 | ﹤0.01% |
+33
| New | +$273 |
2024 Q4
0 quarters
|
|
3314
DELISTED
Brookline Bancorp
BRKL
| $260 | ﹤0.01% |
+22
| New | +$255 |
2024 Q4
0 quarters
|
|
3315
OneSpaWorld
OSW
$2.45B
| $259 | ﹤0.01% |
+13
| New | +$241 |
2024 Q4
0 quarters
|
|
3316
Invesco India ETF
IMVP
$94.8M
| $258 | ﹤0.01% |
10
| – | – |
2022 Q1
11 quarters
|
|
3317
Independent Bank
INDB
$3.65B
| $257 | ﹤0.01% |
4
-6
| -60% | -$400 |
2021 Q4
12 quarters
|
|
3318
Sezzle
SEZL
$4.41B
| $256 | ﹤0.01% |
+6
| New | +$283 |
2024 Q4
0 quarters
|
|
3319
United Fire Group
UFCS
$1.43B
| $256 | ﹤0.01% |
9
| – | – |
2023 Q4
4 quarters
|
|
3320
RPC Inc
RES
$1.31B
| $255 | ﹤0.01% |
43
-22
| -34% | -$136 |
2024 Q2
2 quarters
|
|
3321
JBT Marel
JBTM
$5.51B
| $254 | ﹤0.01% |
2
+1
| +100% | +$115 |
2024 Q2
2 quarters
|
|
3322
CNB Financial Corp
CCNE
$999M
| $249 | ﹤0.01% |
10
| – | – |
2023 Q1
7 quarters
|
|
3323
Sturm, Ruger & Co
RGR
$692M
| $248 | ﹤0.01% |
7
-552
| -99% | -$21.5K |
2019 Q1
23 quarters
|
|
3324
SmartFinancial
SMBK
$859M
| $248 | ﹤0.01% |
+8
| New | +$265 |
2024 Q4
0 quarters
|
|
3325
Amneal Pharmaceuticals
AMRX
$6.77B
| $246 | ﹤0.01% |
31
| – | – |
2023 Q4
4 quarters
|
|
Similar funds
Parallel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 993 reduced and 158 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
- Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
- Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
- Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
- Parallel Advisors opened 275 new positions and closed 158 in Q4 2024.
- Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.
Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.